Aaron P. Scholnik

455 total citations
8 papers, 345 citations indexed

About

Aaron P. Scholnik is a scholar working on Genetics, Oncology and Rheumatology. According to data from OpenAlex, Aaron P. Scholnik has authored 8 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Genetics, 2 papers in Oncology and 2 papers in Rheumatology. Recurrent topics in Aaron P. Scholnik's work include Hemoglobinopathies and Related Disorders (3 papers), Glycosylation and Glycoproteins Research (1 paper) and Ethics in Clinical Research (1 paper). Aaron P. Scholnik is often cited by papers focused on Hemoglobinopathies and Related Disorders (3 papers), Glycosylation and Glycoproteins Research (1 paper) and Ethics in Clinical Research (1 paper). Aaron P. Scholnik collaborates with scholars based in United States and United Kingdom. Aaron P. Scholnik's co-authors include Danielle Laraque, Carolyn Montoya, Linda Edwards, Vanessa Northington Gamble, Llewellyn J. Cornelius, Allison James, Melissa Schori, Charles E. Inturrisi, Lawrence R. Robinson and Magda Mendez and has published in prestigious journals such as Annals of Internal Medicine, Journal of Histochemistry & Cytochemistry and American Journal of Hematology.

In The Last Decade

Aaron P. Scholnik

8 papers receiving 329 citations

Peers

Aaron P. Scholnik

GENET

HEMAT

PPCH

RHEUM

PRM

Matthew M. K. Shing Hong Kong

Erin E. O’Branski United States

Frank G. Keller United States

Natasha M. Archer United States

Alex Wing Kwan Leung Hong Kong

I‐J Hung Taiwan

Siret Ratıp Türkiye

M Vicariot France

A. Bazeos United Kingdom

Suhaib Ahmed Pakistan

Matthew M. K. Shing Hong Kong

Aaron P. Scholnik

124 ×0.5

GENET

99 ×0.6

HEMAT

81 ×1.1

PPCH

24 ×0.6

RHEUM

27 ×0.8

PRM

Citations per year, relative to Aaron P. Scholnik Aaron P. Scholnik (= 1×) peers Matthew M. K. Shing

Countries citing papers authored by Aaron P. Scholnik

Since Specialization

Citations

This map shows the geographic impact of Aaron P. Scholnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron P. Scholnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron P. Scholnik more than expected).

Fields of papers citing papers by Aaron P. Scholnik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron P. Scholnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron P. Scholnik. The network helps show where Aaron P. Scholnik may publish in the future.

Co-authorship network of co-authors of Aaron P. Scholnik

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron P. Scholnik. A scholar is included among the top collaborators of Aaron P. Scholnik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron P. Scholnik. Aaron P. Scholnik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Brawley, Otis W., Llewellyn J. Cornelius, Linda Edwards, et al.. (2008). National Institutes of Health Consensus Development Conference Statement: Hydroxyurea Treatment for Sickle Cell Disease. Annals of Internal Medicine. 148(12). 932–938. 211 indexed citations

2.

Brawley, Otis W., Llewellyn J. Cornelius, Linda Edwards, et al.. (2008). NIH consensus development statement on hydroxyurea treatment for sickle cell disease.. PubMed. 25(1). 1–30. 28 indexed citations

3.

Scholnik, Aaron P., et al.. (2006). Non‐small‐cell lung cancer associated with excessive eosinophilia and secretion of interleukin‐5 as a paraneoplastic syndrome. American Journal of Hematology. 82(3). 234–237. 46 indexed citations

4.

Sherwood, Paula R., Barbara Given, Aaron P. Scholnik, & Charles W. Given. (2004). To Refer or Not to Refer: Factors that Affect Primary Care Provider Referral of Patients with Cancer to Clinical Treatment Trials. Journal of Cancer Education. 19(1). 58–65. 12 indexed citations

5.

Smith, Roy E., Stewart Anderson, Ann Brown, et al.. (2002). Phase II Trial of Doxorubicin/Docetaxel/Cyclophosphamide for Locally Advanced and Metastatic Breast Cancer: Results from NSABP Trial BP-58. Clinical Breast Cancer. 3(5). 333–340. 20 indexed citations

6.

Scholnik, Aaron P., et al.. (1988). High-Dose Folinic Acid and 5-Fluorouracil in the Treatment of Advanced Colon Cancer. American Journal of Clinical Oncology. 11(5). 558–563. 4 indexed citations

7.

Chudwin, David S., et al.. (1977). Fetal Hemoglobin and α-Fetoprotein in Various Malignancies. Acta Haematologica. 58(5). 288–293. 9 indexed citations

8.

Scholnik, Aaron P. & Lawrence Kass. (1973). A DIRECT CYTOCHEMICAL METHOD FOR THE IDENTIFICATION OF LYSOZYME IN VARIOUS TISSUES. Journal of Histochemistry & Cytochemistry. 21(1). 65–72. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact